Davangere Sugar Company to raise USD 100 Million via FCCBs, launches UK subsidiary

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Davangere Sugar Company to raise USD 100 Million via FCCBs, launches UK subsidiary

Davangere Sugar Company has received in-principle approval from BSE & NSE to raise up to USD 100 million via Foreign Currency Convertible Bonds (FCCBs). This capital will fund expansion, including acquiring sugar mills and distilleries. The company also established a 100% owned UK subsidiary, AUREVANT GLOBAL LIMITED.

Davangere Sugar Eyes Expansion with USD 100M FCCB Raise and UK Subsidiary

Davangere Sugar Company plans to raise up to USD 100 million through Foreign Currency Convertible Bonds (FCCBs).
The company has also established a wholly-owned subsidiary in London, UK.

Reader Takeaway: Significant capital raise and international expansion signal growth, but regulatory approvals are key.

What just happened

Davangere Sugar Company has received in-principle approval from the BSE and NSE to issue Foreign Currency Convertible Bonds (FCCBs) aggregating up to USD 100 million. This approval also covers the subsequent issuance of equity shares upon conversion of these bonds. Alongside this, the company has incorporated AUREVANT GLOBAL LIMITED in London, UK, as a wholly-owned subsidiary, with an initial investment of 1000 GBP.

Why this matters

These moves signal a major growth initiative for Davangere Sugar. The substantial capital raise is earmarked for aggressive expansion, including potential acquisitions of integrated sugar mills and ethanol distilleries, strategic investments in other millers, and procurement of new technology. The international subsidiary is a step towards globalizing operations and tapping into new markets for sugar cane products.

The backstory

Davangere Sugar Company has been operating in the sugar industry. The recent incorporation of the UK subsidiary on June 4, 2026, marks a new phase of internationalization. The approval for FCCBs indicates the company's intent to leverage international debt markets for significant funding.

What changes now

The company can now proceed with the necessary steps to finalize the FCCB issuance, subject to meeting exchange conditions. This capital infusion will empower management to pursue strategic acquisitions and capital expenditure plans aimed at scaling up production capacity and enhancing operational efficiency.

Risks to watch

The exchange approval is conditional on several factors, including obtaining all necessary statutory approvals from SEBI, RBI, and MCA, and adherence to the Companies Act. Failure to meet these conditions could lead to the withdrawal of the approval. Investors should track the company's progress in securing these clearances.

Peer comparison

While specific peer data isn't provided in the filing, the move to raise significant capital for expansion and international diversification is a common strategy among listed sugar companies looking to consolidate or grow their market share in a competitive landscape.

Context metrics (time-bound)

The proposed FCCB issue is for up to USD 100 million. The UK subsidiary, AUREVANT GLOBAL LIMITED, was incorporated on June 4, 2026, with an initial capital of 1000 GBP.

What to track next

Investors should closely monitor the company's progress in obtaining final regulatory approvals for the FCCB issuance. Further announcements regarding specific acquisition targets, joint ventures, or partnerships resulting from the fund deployment will be crucial indicators of the company's growth trajectory.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.